Early clinical trial results suggest that a groundbreaking new antibiotic drug could be a “massive game changer” for some patients suffering from chronic lower back pain.

In a world where nicotine consumption is growing more and more popular beyond cigarettes and vapes, Zyns are taking nicotine consumers by storm, showing up in convenience stores all over as they are ...

Supplements like vitamin C and zinc may lessen the severity or duration of cold symptoms should you get sick this winter, ...

The U.S. Food and Drug Administration has approved expanded use of Amgen's drug, Uplizna, to help reduce the risk of flares ...

Sanofi SNY announced that the FDA has granted orphan drug designation to its investigational BTK inhibitor, rilzabrutinib, for the treatment of warm autoimmune hemolytic anemia (wAIHA) and ...